Literature DB >> 28986283

Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice.

Sumitra Pati1, Saritha Krishna2, Jung Hwa Lee3, Matthew K Ross3, Claire B de La Serre4, Donald A Harn5, John J Wagner6, Nikolay M Filipov7, Brian S Cummings8.   

Abstract

Alterations in lipid metabolism play a significant role in the pathogenesis of obesity-associated disorders, and dysregulation of the lipidome across multiple diseases has prompted research to identify novel lipids indicative of disease progression. To address the significant gap in knowledge regarding the effect of age and diet on the blood lipidome, we used shotgun lipidomics with electrospray ionization-mass spectrometry (ESI-MS). We analyzed blood lipid profiles of female C57BL/6 mice following high-fat diet (HFD) and low-fat diet (LFD) consumption for short (6weeks), long (22weeks), and prolonged (36weeks) periods. We examined endocannabinoid levels, plasma esterase activity, liver homeostasis, and indices of glucose tolerance and insulin sensitivity to compare lipid alterations with metabolic dysregulation. Multivariate analysis indicated differences in dietary blood lipid profiles with the most notable differences after 6weeks along with robust alterations due to age. HFD altered phospholipids, fatty acyls, and glycerolipids. Endocannabinoid levels were affected in an age-dependent manner, while HFD increased plasma esterase activity at all time points, with the most pronounced effect at 6weeks. HFD-consumption also altered liver mRNA levels of PPARα, PPARγ, and CD36. These findings indicate an interaction between dietary fat consumption and aging with widespread effects on the lipidome, which may provide a basis for identification of female-specific obesity- and age-related lipid biomarkers.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Aging; Diet; Electrospray ionization-mass spectrometry; Lipidomics; Obesity; Phospholipids

Mesh:

Substances:

Year:  2017        PMID: 28986283     DOI: 10.1016/j.bbalip.2017.09.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  5 in total

1.  Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules.

Authors:  Dong Feng; Chun Ge; Zhao-Yi Tan; Jian-Guo Sun; Yuan Xie; Lan Yao; Cai-Xia Yan; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

2.  Perfluorooctanesulfonic Acid and Perfluorohexanesulfonic Acid Alter the Blood Lipidome and the Hepatic Proteome in a Murine Model of Diet-Induced Obesity.

Authors:  Marisa Pfohl; Lishann Ingram; Emily Marques; Adam Auclair; Benjamin Barlock; Rohitash Jamwal; Dwight Anderson; Brian S Cummings; Angela L Slitt
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

3.  Age- and Diet-Dependent Changes in Hepatic Lipidomic Profiles of Phospholipids in Male Mice: Age Acceleration in Cyp2b-Null Mice.

Authors:  Melissa M Heintz; Ramiya Kumar; Kristal M Maner-Smith; Eric A Ortlund; William S Baldwin
Journal:  J Lipids       Date:  2022-03-29

4.  A high fat diet with a high C18:0/C16:0 ratio induced worse metabolic and transcriptomic profiles in C57BL/6 mice.

Authors:  Liqiang Wang; Fei Xu; Zhenfeng Song; Dan Han; Jingyi Zhang; Linjun Chen; Lixin Na
Journal:  Lipids Health Dis       Date:  2020-07-21       Impact factor: 3.876

5.  High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue.

Authors:  Eline N Kuipers; Vasudev Kantae; Boukje C Eveleens Maarse; Susan M van den Berg; Robin van Eenige; Kimberly J Nahon; Anne Reifel-Miller; Tamer Coskun; Menno P J de Winther; Esther Lutgens; Sander Kooijman; Amy C Harms; Thomas Hankemeier; Mario van der Stelt; Patrick C N Rensen; Mariëtte R Boon
Journal:  Front Physiol       Date:  2019-01-10       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.